These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3284821)

  • 1. Role of angiotensin II in renal prostaglandin E2 production after furosemide administration.
    Fujimura A; Ebihara A
    Hypertension; 1988 May; 11(5):491-4. PubMed ID: 3284821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of propranolol on urinary prostaglandin E2 after frusemide administration in healthy subjects.
    Fujimura A; Kajiyama H; Ebihara A
    Eur J Clin Pharmacol; 1987; 31(5):605-7. PubMed ID: 3549322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of furosemide on angiotensin II-mediated prostaglandin I2 production in hypertensive subjects.
    Fujimura A; Ebihara A
    Eur J Clin Pharmacol; 1990; 39(2):113-5. PubMed ID: 2253658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of furosemide-induced natriuresis by direct stimulation of renal prostaglandin E2.
    Katayama S; Attallah AA; Stahl RA; Bloch DL; Lee JB
    Am J Physiol; 1984 Oct; 247(4 Pt 2):F555-61. PubMed ID: 6594069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis.
    Ljubicić N; Bilić A; Plavsić V
    Eur J Clin Pharmacol; 1992; 43(5):555-8. PubMed ID: 1483495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of furosemide, captopril and indometacin on the renin-angiotensin system and the renal prostaglandins in anesthetized neonatal piglets.
    Joppich R; Weyer P; Eife R
    Arzneimittelforschung; 1995 Jul; 45(7):822-5. PubMed ID: 8573231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of captopril on urinary excretion of furosemide in hypertensive subjects.
    Fujimura A; Shimokawa Y; Ebihara A
    J Clin Pharmacol; 1990 Jun; 30(6):538-42. PubMed ID: 2191978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
    MacDonald TM; Craig K; Watson ML
    Br J Clin Pharmacol; 1989 Dec; 28(6):683-94. PubMed ID: 2532921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Sar1-Ileu8-angiotensin on renal prostaglandin E2 biosynthesis and excretion.
    Katayama S; Attallah AA; Stahl RA; Lee JB
    J Lab Clin Med; 1987 Apr; 109(4):504-8. PubMed ID: 3546565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol stimulates rat renopapillary prostaglandin E2 (PGE2), but not PGF2 alpha biosynthesis.
    Katayama S; Lee JB
    Endocrinology; 1985 Aug; 117(2):656-61. PubMed ID: 3893988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of indomethacin on furosemide-stimulated urinary PGE2 excretion in man.
    Brater DC; Beck JM; Adams BV; Campbell WB
    Eur J Pharmacol; 1980 Jul; 65(2-3):213-9. PubMed ID: 7398787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furosemide-induced alterations in the electrolyte status, the function of renin-angiotensin-aldosterone system, and the urinary excretion of prostaglandins in newborn infants.
    Sulyok E; Varga F; Németh M; Tényi I; Csaba IF; Ertl T; Györy E
    Pediatr Res; 1980 May; 14(5):765-8. PubMed ID: 6992087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endogenous prostaglandins in volume expansion and during furosemide infusion in conscious dogs.
    Sreenivasan V; Walker B; Krasney J; Mookerjee B; Venuto R
    Hypertension; 1981; 3(1):59-66. PubMed ID: 7203606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renin and aldosterone secretion under converting enzyme inhibition].
    Nakamura K
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
    J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of PGE2 infusion on renal function in normal man before and after angiotensin II inhibition by captopril.
    Usberti M; Cianciaruso B; Di Minno G; Auciello A; Ardillo G; Bonanno D; Conte G; Andreucci VE
    Ren Physiol; 1987; 10(5):289-96. PubMed ID: 3331474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.